China's health ministry called on local authorities to expand fever clinic capacity as the country grapples with the surge of respiratory illnesses this winter. The spike of Pneumonia became an international issue last week when the WHO asked China for clarity on pneumonia clusters, especially among children. China cites the simultaneous spread of multiple pathogens, prominently influenza, as driving the outbreaks. Still, questions linger on transparency early in the pandemic. Officials now warn influenza will peak this winter while COVID risks rebounding after restrictions eased. They urge strengthened reporting and prevention measures in crowded areas like schools to control spread. But hospital waits signal China remains overwhelmed by a confluence of untimely viral threats.

Amid worries over a pneumonia outbreak in China, India's Health Ministry said it is "closely monitoring" respiratory illness clusters and H9N2 cases there but the risk is low currently. The WHO noted China reported a virus uptick after lifting COVID-19 curbs. Some Chinese hospitals are seeing 7,000 patients daily. The Indian ministry said "The overall risk assessment by the WHO indicates a low probability of human to human spread" of H9N2 so far. It recognized the need for "strengthening surveillance among human, animal husbandry, and wildlife sectors." The ministry asserted "India is prepared for any kind of public health exigency" as China tackles the surge. With China witnessing an increase in pneumonia and flu, India said it is keeping a close watch but is prepared to handle any crisis situation.

China has informed the World Health Organisation (WHO) that the surge in respiratory illnesses is not linked to unusual viruses but is associated with the easing of Covid-19 restrictions. Citing known pathogens like mycoplasma pneumonia, Chinese health authorities shared data revealing the connection between the rise in cases and the relaxation of pandemic measures. The WHO had sought information following reports of pneumonia clusters in children. In response, China emphasized routine data sharing, while both entities face scrutiny over transparency, reminiscent of early Covid-19 reporting. The situation is being monitored amid global health concerns. China is facing an average of 7,000 patients daily with the mysterious pneumonia. 

China is grappling with a mysterious pneumonia outbreak affecting children in Beijing and Liaoning province, prompting concerns among global health experts. Pediatric hospitals are overwhelmed, leading to class suspensions. Symptoms include high fever and lung inflammation without a cough. ProMed alerts on undiagnosed pneumonia, suggesting a link to schools. Speculation points to mycoplasma pneumoniae. Despite the surge since October, no deaths are reported. The World Health Organization formally requests detailed information from China, emphasizing the unclear association with overall respiratory infections. Chinese authorities attribute the rise to post-COVID-19 measures and known pathogens, emphasizing enhanced disease surveillance. [ photo courtesy: China in pictures/X ]

A UK health expert has warned that Disease X, a mysterious hypothetical pathogen identified by WHO, could potentially cause a more devastating pandemic than COVID-19. Kate Bingham cautioned Disease X could spark a crisis on the scale of the 1918 Spanish Flu that killed 50 million. She stressed the urgent need to prepare for rapid mass vaccination drives if the unknown Disease X emerges. With COVID-19 mortality lower than viruses like Ebola, Bingham warned against complacency as factors like deforestation enable animal viruses to infect humans. Her warning highlights the looming threat of Disease X potentially unleashing an even more calamitous pandemic.

The Kerala government confirmed in the state assembly that the recent deaths due to the Nipah virus in Kozhikode were caused by the 'Bangladesh variant' of the brain-damaging virus. Health Minister Veena George said this strain has a high mortality rate but is less infectious compared to other variants. This marks the fourth Nipah outbreak in Kerala since 2018, which has so far claimed 25 lives out of 27 infected. The virus, which spreads through direct contact with bodily fluids of infected bats, pigs, or humans, has no vaccine or treatment available yet. Kerala first reported Nipah in 2018 when 21 out of 23 infected people died. In 2019 and 2021, two more lives were lost to Nipah outbreaks in the state.